BioHealth News Archive
GSK to support manufacture of Novavax’ COVID-19 vaccine | GSK
GSK has reached an agreement in principle with Novavax and the UK Government Vaccines Taskforce to support manufacturing of up to 60 million doses…
Read MoreShould College Students Be Prioritized for Covid-19 Vaccines Now?
As the supply of Covid-19 vaccines begins to widen toward meeting the immense demand, some observers have proposed that policy makers put college students…
Read MoreThe BioHealth Capital Region, Epicenter of U.S. Regulatory Infrastructure · BioBuzz
The region has been at the forefront of the SARS-CoV-2 vaccine race, and it is rapidly becoming a center for advanced manufacturing. The BHCR…
Read MoreBHCR passes San Francisco in NIH funding · BioBuzz
The National Institutes of Health provides significant funding for drug development research to universities, companies, and organizations. Over the course of 2020, the NIH…
Read MoreGSK to support the manufacturing of Novavax COVID-19 vaccine | Procurement & Supply Chain | Manufacturing Global
“I’m delighted by GSK’s investment, which shows the strength of UK manufacturing, and will further boost our vaccine rollout. The Vaccines Taskforce has worked…
Read MoreMassachusetts-Based Cell Therapy Company Coming to Rockville | Montgomery Community Media
TCR² Therapeutics Inc., based in Cambridge, is a clinical-stage company that develops T-cell therapies for patients with cancer. In a statement, TCR² said it…
Read MoreBioHealth Innovation Recruiting Managing Director, Economic Development Position
Montgomery County, Maryland County Executive Marc Elrich has notified the Montgomery County Council of his appointment of BHI's Managing Director for Economic Development, Judy…
Read MoreFireside Chat – Development of Countermeasures for Viral Diseases – Webinar Registration – Zoom
Development of Countermeasures for Viral Diseases The best defense against viral infectious diseases are safe and effective medical countermeasures that function at level of…
Read MoreTCR² Therapeutics Establishes Commercial-Scale Cell Therapy Manufacturing Facility — TCR2 Therapeutics
CAMBRIDGE, Mass., March 29, 2021 (GLOBE NEWSWIRE) -- TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage cell therapy company with a pipeline of novel T cell…
Read MoreBioFactura Funded $13M Contract Option for Smallpox Biodefense Therapeutic | Global Biodefense
BioFactura, Inc. today announced a contract option activation of over $13 million by the Biomedical Advanced Research and Development Authority (BARDA), part of the…
Read More8 digital health trends emerging from the pandemic – Technical.ly Baltimore
What did we learn during the pandemic, and what should we watch moving forward? Those are two of the key questions that many professional…
Read More209 PERRY PARKWAY – GAITHERSBURG, MARYLAND, 20877
SPACE FEATURES Existing laboratory suite with closed and open o ices Grade-level loading doors 17' ceiling heights • breakroom with kitchenette 180 free surface…
Read MoreWhat It Takes to Manufacture a Vaccine | NAM
You may not know it, but one company has the capacity to manufacture bulk drug substance for more than a billion doses of COVID-19…
Read MoreLeveraging Artificial Intelligence in Human Health | B.S. in Biocomputational Engineering
The University of Maryland hosted a free webinar, Leveraging Artificial Intelligence in Human Health, on Friday, March 19, 2020. This event featured a fireside chat with Dr. Robert…
Read MoreNorthern Virginia’s bioscience industry grows stronger | WTOP
Exciting things are happening at Innovation Park in Manassas. Researchers are working on global solutions, industry jobs are on the rise, and new facilities…
Read More